Melatonin, also known as N-Acetyl-5-methoxytryptamine or Circadin, is an endogenous hormone primarily produced by the pineal gland in the brain. It belongs to the class of indoleamines and is synthesized from the amino acid tryptophan. Melatonin is also available in synthetic form for research and therapeutic purposes. Researchers have extensively studied melatonin for its role in regulating circadian rhythms and sleep-wake cycles. It is also involved in modulating seasonal biological functions and has been investigated for its antioxidant properties and potential effects on mood disorders. Melatonin acts primarily through melatonin receptors MT1 and MT2, which are G-protein-coupled receptors. Activation of these receptors influences the sleep-wake cycle by modulating the release of neurotransmitters and hormones involved in circadian regulation. Researchers have observed that melatonin's action involves the inhibition of adenylate cyclase and the modulation of intracellular cAMP levels. The pharmacokinetic properties of melatonin include a short circulating half-life of approximately 20 to 50 minutes. It is metabolized primarily in the liver by cytochrome P450 enzymes, particularly CYP1A2. Oral bioavailability is low due to significant first-pass metabolism. Clinically, melatonin is used for the management of sleep disorders, particularly in cases of insomnia and jet lag. In many countries, it is available over-the-counter, while in others, it may require a prescription. Researchers have found it to be generally well-tolerated, with a favorable safety profile. Regulatory standing varies by country, reflecting differences in classification and availability.